Weather
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Capricor Therap (NQ: CAPR )

8.582 +2.612 (+43.75%)
Streaming Delayed Price Updated: 2:09 PM EDT, Sep 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,026,127
Open 8.430
Bid (Size) 8.580 (20)
Ask (Size) 8.600 (2)
Prev. Close 5.970
Today's Range 7.424 - 9.245
52wk Range 2.680 - 7.280
Shares Outstanding 32,538,930
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Capricor Therapeutics Stock Is Soaring Tuesday
Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a biologics license application (BLA) for the full approval of Deramiocel for the... 
Via Benzinga
Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy
Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and... 
Via Talk Markets

Performance

YTD
+67.62%
+67.62%
1 Month
+75.50%
+75.50%
3 Month
+79.17%
+79.17%
6 Month
+29.44%
+29.44%
1 Year
+54.63%
+54.63%

More News

Read More
Deep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm
Via Benzinga
Unveiling 6 Analyst Insights On Capricor Therapeutics
Via Benzinga
What's Going On With Capricor Therapeutics Stock Friday?
Via Benzinga
Expert Ratings For Capricor Therapeutics
Via Benzinga
Recap: Capricor Therapeutics Q4 Earnings
Via Benzinga
Earnings Scheduled For February 29, 2024
Via Benzinga
Capricor Therapeutics's Earnings Outlook
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
What's Going On With Capricor Therapeutics Stock Tuesday?
Via Benzinga
What's Going On With Capricor Therapeutics Stock Tuesday?
Via Benzinga
CAPR Stock Earnings: Capricor Therapeutics Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Preview: Capricor Therapeutics's Earnings
Via Benzinga
FlexShopper And 3 Other Penny Stocks Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Turn Lower; Dow Tumbles Over 200 Points
Via Benzinga
Topics Stocks
Exposures US Equities
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Down 1% Following PCE Data; Blue Apron Shares Surge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Top 5 Health Care Stocks That May Fall Off A Cliff
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.